Publications
This page highlights UQ-led research in extracellular vesicles (EVs), spanning discovery, technology development, and emerging clinical applications.
The selected publications reflect contributions to therapeutics, disease research, and advanced characterisation, supporting the translation of EV science into real-world health outcomes.
- To access each publication, expand the dropdown below and follow the DOI link provided.
- Each DOI will take you directly to the full paper or publisher’s page for more detailed information.
DOI linked to each paper
- Platelet-derived purified exosome product (PEP): A clinical-grade lyophilized extracellular vesicle product with broad therapeutic potential, including kidney repair.
(DOI: 10.26599/NR.2026.94908496)
- Therapeutic effects of platelet-derived extracellular vesicles on viral myocarditis correlate with biomolecular content.
(DOI: 10.3389/fimmu.2024.1468969)
- Donor-dependent heterogeneity in therapeutic effects of adipose tissue extracellular vesicles.
(DOI: 10.1186/s12964-025-02563-8)
- Extracellular Vesicles and B Cell Interactions: B-Side Track or Greatest Hit?
(DOI: 10.1021/acsnano.5c07444)
- Lipoprotein Association Fluorometry (LAF) as a Semi‐Quantitative Characterization Tool to Assess Extracellular Vesicle‐Lipoprotein Binding.
(DOI: 10.1002/jev2.70172)
- Adipose stem cell-derived nanovesicles for cardioprotection: production and identification of therapeutic components.
(DOI: 10.1016/j.jconrel.2025.113989)
- Cancer-derived extracellular vesicles in natural killer cell immune evasion: molecular mechanisms and therapeutic insights.
(DOI: 10.1016/j.ymthe.2025.05.038)
- Increasing the biomolecular relevance of cell culture practice.
(DOI: 10.1186/s12929-024-01095-6)
- Immunogenicity of Extracellular Vesicles.
(DOI: 10.1002/adma.202403199)
- Chemically-Induced Lipoprotein Breakdown for Improved Extracellular Vesicle Purification.
(DOI: 10.1002/smll.202307240)
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.
(DOI: 10.1002/jev2.12404)
- High-throughput analysis of glycan sorting into extracellular vesicles.
(DOI: 10.1016/j.bbamcr.2023.119641)
- Entry and exit of extracellular vesicles to and from the blood circulation.
(DOI: 10.1038/s41565-023-01522-z)
- Extracellular Vesicle and Lipoprotein Interactions.
(DOI: 10.1021/acs.nanolett.3c03579)
- Reconstituted Extracellular Vesicles from Human Platelets Decrease Viral Myocarditis in Mice.
(DOI: 10.1002/smll.202303317)
- Extracellular vesicle lipids in cancer immunoevasion.
(DOI: 10.1016/j.trecan.2023.08.006)
- Clinical Translation of Extracellular Vesicles.
(DOI: 10.1002/adhm.202301010)
- Vasculature organotropism in drug delivery.
(DOI: 10.1016/j.addr.2023.115054)
- Hyaluronic acid: An overlooked extracellular vesicle contaminant.
(DOI: 10.1002/jev2.12362)
- Extracellular vesicles as personalized medicine.
(DOI: 10.1016/j.mam.2022.101155)
- Glycan Node Analysis Detects Varying Glycosaminoglycan Levels in Melanoma-Derived Extracellular Vesicles.
(DOI: 10.3390/ijms24108506)
- RAB27B Drives a Cancer Stem Cell Phenotype in NSCLC Cells Through Enhanced Extracellular Vesicle Secretion.
(DOI: 10.1158/2767-9764)
- Unraveling multilayered extracellular vesicles: Speculation on cause.
(DOI: 10.1002/jev2.12309)
- Sucrose-based cryoprotective storage of extracellular vesicles.
(DOI: 10.1016/j.vesic.2022.100016)
- The cancer cell-derived extracellular vesicle glycocode in immunoevasion.
(DOI: 10.1016/j.it.2022.09.004)
- Extracellular vesicle glucose transporter-1 and glycan features in monocyte-endothelial inflammatory interactions.
(DOI: 10.1016/j.nano.2022.102515)
- Considerations for extracellular vesicle and lipoprotein interactions in cell culture assays.
(DOI: 10.1002/jev2.12202)
- Effects of Adipose-Derived Biogenic Nanoparticle-Associated microRNA-451a on Toll-like Receptor 4-Induced Cytokines.
(DOI: 10.3390/pharmaceutics14010016)
- Extracellular vesicle therapeutics from plasma and adipose tissue.
(DOI: 10.1016/j.nantod.2021.101159)
- A Simple and Quick Method for Loading Proteins in Extracellular Vesicles.
(DOI: 10.3390/ph14040356)
- Extracellular vesicles versus synthetic nanoparticles for drug delivery.
(DOI: 10.1038/s41578-020-00277-6)
- Extracellular Vesicles in Cancer Detection: Hopes and Hypes.
(DOI: 10.1016/j.trecan.2020.09.003)
- Extracellular vesicles for treatment of solid organ ischemia–reperfusion injury.
(DOI: 10.1111/ajt.16164)
- Brain metastases-derived extracellular vesicles induce binding and aggregation of low-density lipoprotein.
(DOI: 10.1186/s12951-020-00722-2)
- Glycan Node Analysis of Plasma-Derived Extracellular Vesicles.
(DOI: 10.3390/cells9091946)
- Adipose-Derived Biogenic Nanoparticles for Suppression of Inflammation.
(DOI: 10.1002/smll.201904064)
- Extracellular vesicle-based drug delivery systems for cancer treatment.
(DOI: 10.7150/thno.37097)
- Adipose-derived cellular and cell-derived regenerative therapies in dermatology and aesthetic rejuvenation.
(DOI: 10.1016/j.arr.2019.100933)
- Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles.
(DOI: 10.1007/s10544-019-0396-7)
- Clinical cancer nanomedicine.
(DOI: 10.1016/j.nantod.2019.02.005)
- Tangential Flow Filtration for Highly Efficient Concentration of Extracellular Vesicles from Large Volumes of Fluid.
(DOI: 10.3390/cells7120273)
- Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.
(DOI: 10.1080/20013078.2018.1535750)
- Extracellular vesicle therapeutics for liver disease.
(DOI: 10.1016/j.jconrel.2018.01.022)
- Extracellular vesicles for treatment of solid organ ischemia-reperfusion injury.
(DOI: 10.1111/ajt.16164)